Showing results (2631-2640 of 6,717) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|April 5, 2016
Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysisXiao-Jun Wu, Yi Zhi, Peng He, et al.Oncotargets and Therapy|April 5, 2016
Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysisHui Shen, Ming Zhan, Wei Wang, et al.Oncotargets and Therapy|August 10, 2017
Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinomaWenjun Ni, Erlin Song, Mancheng Gong, et al.Oncotargets and Therapy|August 10, 2017
Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapyYu Bai, Hai-Wei Wu, Xu Ma, et al.Oncotargets and Therapy|August 10, 2017
Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutationsXinyu Song, Zhehai WangOncotargets and Therapy|August 10, 2017
The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapyYuan Wang, Guo-Fang Hu, Zhe-Hai WangOncotargets and Therapy|August 10, 2017
Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysisQiaowei Fan, Bingrong LiuOncotargets and Therapy|August 10, 2017
Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics studyLi Gao, Sheng-Hua Li, Yi-Xin Tian, et al.Oncotargets and Therapy|August 11, 2017
Volumetric modulated arc therapy for treatment of solid tumors: current insightsGabriella Macchia, Francesco Deodato, Savino Cilla, et al.Oncotargets and Therapy|August 11, 2017
MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjectsWenfeng Hua, Anqi Zhang, Ping Duan, et al.Pageof 672